Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540488 · ClinicalTrials.gov registry record · Phase 3
Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 54
- Enrollment target
NCT00540488: Completed Phase 3 study, sponsored by Abbott Nutrition.
NCT00540488 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 54 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00540488, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 54 participants
- Enrollment target
Study Summary
To measure and compare the glycemic and insulinemic responses of subjects consuming a standard and two diabetes-specific products.
Interventions
- OTHER Adult enteral formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2002-08 |
| Phase | Phase 3 |
What the finished NCT00540488 record still lists
NCT00540488 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Adult enteral formula is the first listed.
NCT00540488 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00540488 about?
NCT00540488 is a clinical study titled "Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas". To measure and compare the glycemic and insulinemic responses of subjects consuming a standard and two diabetes-specific products.
What is the current status of trial NCT00540488?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 54 participants. The study started on 2002-08.
What interventions are being tested in trial NCT00540488?
The interventions under investigation include: Adult enteral formula (OTHER).
Who is sponsoring clinical trial NCT00540488?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00540488's enrollment target sits among peer trials
54 1838th of 2000 higher than 162 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia